WHO Grade 1 Glioma — Trials

WHO Grade 1 Glioma — Trials · CancerIndex

Clinical trials

Registered studies

36 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01553149	Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma	completed	Phase 2	75	National Cancer Institute (NCI)NIH	4	Jan 7, 2025	clinicaltrials
NCT02684058	Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors	completed	Phase 2	151	Novartis PharmaceuticalsINDUSTRY	20	Dec 13, 2023	clinicaltrials
NCT00823459	Everolimus in Treating Patients With Recurrent Low-Grade Glioma	completed	Phase 2	58	Susan ChangOTHER	1	Jul 28, 2020	clinicaltrials
NCT01462695

Data updated 23 days agoSource updated Jan 7, 2025source: clinicaltrials